Pentasa Caps FDA- Approved For New Administration Approach

Pentasa Caps FDA- Approved For New Administration Approach
The Food and Drug Administration (FDA) recently approved a supplemental New Drug Application (sNDA) for Pentasa (melamine), updating the therapy’s path of administration. Now, the Pentasa capsules can be opened and the contents can be sprinkled onto yogurt or applesauce. Pentasa is a salicylate appropriated to induce both the remission and the treatment of individuals suffering with mild to moderate active ulcerative

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *